Open AccessOral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients With Blood Cancers
Author(s) -
Stacie B. Dusetzina,
Haiden A. Huskamp,
Shelley A. Jazowski,
Aaron Winn,
William A. Wood,
Adam J. Olszewski,
Ethan Basch,
Nancy L. Keating
Publication year - 2019
Publication title -
journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djz243
Subject(s) - medicine , discontinuation , parity (physics) , observational study , multiple myeloma , nothing , physics , particle physics , philosophy , epistemology
In this study, we sought to estimate the association between oral oncology parity law adoption and anticancer medication use for patients with chronic myeloid leukemia or multiple myeloma.